A Review: Pharmaceutical and Pharmacologic Treatments Used In Covid-19
Received Date: Jan 04, 2022 / Accepted Date: Jan 24, 2022 / Published Date: Jan 31, 2022
Abstract
Importance: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection. Vaccination is currently the best bet for the prevention of COVID-19. Still, in its absence, there has been considerable interest in repurposing existing therapeutic agents to reduce the severity of the illness and ease the burden on the already strained healthcare systems. This review outlines the current evidence regarding proposed treatments experimental or repurposed, for COVID-19, and gives an insight into the clinical trial landscape for drugs as well as vaccines.
Citation: Mendhi SM, More SM, Nagbhidkar AP, Sarode M (2022) A Review: Pharmaceutical and Pharmacologic Treatments Used In Covid-19. Clin Pharmacol Biopharm 11: 246. Doi: 10.4172/2167-065X.1000246
Copyright: © 2022 Mendhi SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1357
- [From(publication date): 0-2022 - May 18, 2024]
- Breakdown by view type
- HTML page views: 1007
- PDF downloads: 350
